Global Parkinson's Disease (PD) Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson's Disease (PD) Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Parkinson's Disease (PD) Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Parkinson's Disease (PD) Drugs by Country/Region, 2017, 2022 & 2028

2.2 Parkinson's Disease (PD) Drugs Segment by Type

2.2.1 Dopamine Agonist

2.2.2 Monoamine Oxidase Inhibitors

2.2.3 Acetylcholinesterase Inhibitors

2.2.4 Glutamate Inhibitors

2.3 Parkinson's Disease (PD) Drugs Sales by Type

2.3.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Parkinson's Disease (PD) Drugs Sale Price by Type (2017-2022)

2.4 Parkinson's Disease (PD) Drugs Segment by Application

2.4.1 Hospital

2.4.2 Family

2.5 Parkinson's Disease (PD) Drugs Sales by Application

2.5.1 Global Parkinson's Disease (PD) Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Parkinson's Disease (PD) Drugs Sale Price by Application (2017-2022)

3 Global Parkinson's Disease (PD) Drugs by Company

3.1 Global Parkinson's Disease (PD) Drugs Breakdown Data by Company

3.1.1 Global Parkinson's Disease (PD) Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Company (2020-2022)

3.2 Global Parkinson's Disease (PD) Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Parkinson's Disease (PD) Drugs Revenue by Company (2020-2022)

3.2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Parkinson's Disease (PD) Drugs Sale Price by Company

3.4 Key Manufacturers Parkinson's Disease (PD) Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Parkinson's Disease (PD) Drugs Product Location Distribution

3.4.2 Players Parkinson's Disease (PD) Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Parkinson's Disease (PD) Drugs by Geographic Region

4.1 World Historic Parkinson's Disease (PD) Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Parkinson's Disease (PD) Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Parkinson's Disease (PD) Drugs Annual Revenue by Geographic Region

4.2 World Historic Parkinson's Disease (PD) Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Parkinson's Disease (PD) Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Parkinson's Disease (PD) Drugs Annual Revenue by Country/Region

4.3 Americas Parkinson's Disease (PD) Drugs Sales Growth

4.4 APAC Parkinson's Disease (PD) Drugs Sales Growth

4.5 Europe Parkinson's Disease (PD) Drugs Sales Growth

4.6 Middle East & Africa Parkinson's Disease (PD) Drugs Sales Growth

5 Americas

5.1 Americas Parkinson's Disease (PD) Drugs Sales by Country

5.1.1 Americas Parkinson's Disease (PD) Drugs Sales by Country (2017-2022)

5.1.2 Americas Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022)

5.2 Americas Parkinson's Disease (PD) Drugs Sales by Type

5.3 Americas Parkinson's Disease (PD) Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson's Disease (PD) Drugs Sales by Region

6.1.1 APAC Parkinson's Disease (PD) Drugs Sales by Region (2017-2022)

6.1.2 APAC Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022)

6.2 APAC Parkinson's Disease (PD) Drugs Sales by Type

6.3 APAC Parkinson's Disease (PD) Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Parkinson's Disease (PD) Drugs by Country

7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2022)

7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022)

7.2 Europe Parkinson's Disease (PD) Drugs Sales by Type

7.3 Europe Parkinson's Disease (PD) Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson's Disease (PD) Drugs by Country

8.1.1 Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Type

8.3 Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs

10.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs

10.4 Industry Chain Structure of Parkinson's Disease (PD) Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Parkinson's Disease (PD) Drugs Distributors

11.3 Parkinson's Disease (PD) Drugs Customer

12 World Forecast Review for Parkinson's Disease (PD) Drugs by Geographic Region

12.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region

12.1.1 Global Parkinson's Disease (PD) Drugs Forecast by Region (2023-2028)

12.1.2 Global Parkinson's Disease (PD) Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Parkinson's Disease (PD) Drugs Forecast by Type

12.7 Global Parkinson's Disease (PD) Drugs Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Offered

13.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Offered

13.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Parkinson's Disease (PD) Drugs Product Offered

13.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Teva Pharmaceutical Industries

13.4.1 Teva Pharmaceutical Industries Company Information

13.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Offered

13.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teva Pharmaceutical Industries Main Business Overview

13.4.5 Teva Pharmaceutical Industries Latest Developments

13.5 AbbVie

13.5.1 AbbVie Company Information

13.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Offered

13.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AbbVie Main Business Overview

13.5.5 AbbVie Latest Developments

13.6 Abital Pharma

13.6.1 Abital Pharma Company Information

13.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Offered

13.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Abital Pharma Main Business Overview

13.6.5 Abital Pharma Latest Developments

13.7 Addex Therapeutics

13.7.1 Addex Therapeutics Company Information

13.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Offered

13.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Addex Therapeutics Main Business Overview

13.7.5 Addex Therapeutics Latest Developments

13.8 Biogen

13.8.1 Biogen Company Information

13.8.2 Biogen Parkinson's Disease (PD) Drugs Product Offered

13.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biogen Main Business Overview

13.8.5 Biogen Latest Developments

13.9 Eisai

13.9.1 Eisai Company Information

13.9.2 Eisai Parkinson's Disease (PD) Drugs Product Offered

13.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eisai Main Business Overview

13.9.5 Eisai Latest Developments

13.10 Eli Lilly

13.10.1 Eli Lilly Company Information

13.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Offered

13.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Eli Lilly Main Business Overview

13.10.5 Eli Lilly Latest Developments

13.11 F. Hoffmann-La Roche

13.11.1 F. Hoffmann-La Roche Company Information

13.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Offered

13.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 F. Hoffmann-La Roche Main Business Overview

13.11.5 F. Hoffmann-La Roche Latest Developments

13.12 H. Lundbeck

13.12.1 H. Lundbeck Company Information

13.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Offered

13.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 H. Lundbeck Main Business Overview

13.12.5 H. Lundbeck Latest Developments

13.13 Impax Laboratories

13.13.1 Impax Laboratories Company Information

13.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Offered

13.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Impax Laboratories Main Business Overview

13.13.5 Impax Laboratories Latest Developments

13.14 Kyowa Hakko Kirin

13.14.1 Kyowa Hakko Kirin Company Information

13.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Offered

13.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Kyowa Hakko Kirin Main Business Overview

13.14.5 Kyowa Hakko Kirin Latest Developments

13.15 Otsuka Pharmaceutical

13.15.1 Otsuka Pharmaceutical Company Information

13.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Offered

13.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Otsuka Pharmaceutical Main Business Overview

13.15.5 Otsuka Pharmaceutical Latest Developments

13.16 Pfizer

13.16.1 Pfizer Company Information

13.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Offered

13.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Pfizer Main Business Overview

13.16.5 Pfizer Latest Developments

14 Research Findings and Conclusion

Table 1. Parkinson's Disease (PD) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Parkinson's Disease (PD) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Dopamine Agonist

Table 4. Major Players of Monoamine Oxidase Inhibitors

Table 5. Major Players of Acetylcholinesterase Inhibitors

Table 6. Major Players of Glutamate Inhibitors

Table 7. Global Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Parkinson's Disease (PD) Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022)

Table 15. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Parkinson's Disease (PD) Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Parkinson's Disease (PD) Drugs Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Parkinson's Disease (PD) Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Parkinson's Disease (PD) Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Parkinson's Disease (PD) Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Parkinson's Disease (PD) Drugs Producing Area Distribution and Sales Area

Table 23. Players Parkinson's Disease (PD) Drugs Products Offered

Table 24. Parkinson's Disease (PD) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Parkinson's Disease (PD) Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Parkinson's Disease (PD) Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Parkinson's Disease (PD) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Parkinson's Disease (PD) Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Parkinson's Disease (PD) Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Parkinson's Disease (PD) Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Parkinson's Disease (PD) Drugs

Table 68. Key Market Challenges & Risks of Parkinson's Disease (PD) Drugs

Table 69. Key Industry Trends of Parkinson's Disease (PD) Drugs

Table 70. Parkinson's Disease (PD) Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Parkinson's Disease (PD) Drugs Distributors List

Table 73. Parkinson's Disease (PD) Drugs Customer List

Table 74. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Parkinson's Disease (PD) Drugs Sales Market Forecast by Region

Table 76. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Parkinson's Disease (PD) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Parkinson's Disease (PD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Parkinson's Disease (PD) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Parkinson's Disease (PD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Boehringer Ingelheim Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Offered

Table 96. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Boehringer Ingelheim Main Business

Table 98. Boehringer Ingelheim Latest Developments

Table 99. GlaxoSmithKline Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Offered

Table 101. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. GlaxoSmithKline Main Business

Table 103. GlaxoSmithKline Latest Developments

Table 104. Novartis Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Novartis Parkinson's Disease (PD) Drugs Product Offered

Table 106. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Novartis Main Business

Table 108. Novartis Latest Developments

Table 109. Teva Pharmaceutical Industries Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Offered

Table 111. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Teva Pharmaceutical Industries Main Business

Table 113. Teva Pharmaceutical Industries Latest Developments

Table 114. AbbVie Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. AbbVie Parkinson's Disease (PD) Drugs Product Offered

Table 116. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. AbbVie Main Business

Table 118. AbbVie Latest Developments

Table 119. Abital Pharma Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Abital Pharma Parkinson's Disease (PD) Drugs Product Offered

Table 121. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Abital Pharma Main Business

Table 123. Abital Pharma Latest Developments

Table 124. Addex Therapeutics Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Offered

Table 126. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Addex Therapeutics Main Business

Table 128. Addex Therapeutics Latest Developments

Table 129. Biogen Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Biogen Parkinson's Disease (PD) Drugs Product Offered

Table 131. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Biogen Main Business

Table 133. Biogen Latest Developments

Table 134. Eisai Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Eisai Parkinson's Disease (PD) Drugs Product Offered

Table 136. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Eisai Main Business

Table 138. Eisai Latest Developments

Table 139. Eli Lilly Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Eli Lilly Parkinson's Disease (PD) Drugs Product Offered

Table 141. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Eli Lilly Main Business

Table 143. Eli Lilly Latest Developments

Table 144. F. Hoffmann-La Roche Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Offered

Table 146. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. F. Hoffmann-La Roche Main Business

Table 148. F. Hoffmann-La Roche Latest Developments

Table 149. H. Lundbeck Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. H. Lundbeck Parkinson's Disease (PD) Drugs Product Offered

Table 151. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. H. Lundbeck Main Business

Table 153. H. Lundbeck Latest Developments

Table 154. Impax Laboratories Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Impax Laboratories Parkinson's Disease (PD) Drugs Product Offered

Table 156. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. Impax Laboratories Main Business

Table 158. Impax Laboratories Latest Developments

Table 159. Kyowa Hakko Kirin Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Offered

Table 161. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 162. Kyowa Hakko Kirin Main Business

Table 163. Kyowa Hakko Kirin Latest Developments

Table 164. Otsuka Pharmaceutical Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Offered

Table 166. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 167. Otsuka Pharmaceutical Main Business

Table 168. Otsuka Pharmaceutical Latest Developments

Table 169. Pfizer Basic Information, Parkinson's Disease (PD) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Pfizer Parkinson's Disease (PD) Drugs Product Offered

Table 171. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 172. Pfizer Main Business

Table 173. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Parkinson's Disease (PD) Drugs

Figure 2. Parkinson's Disease (PD) Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Parkinson's Disease (PD) Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Parkinson's Disease (PD) Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Parkinson's Disease (PD) Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Dopamine Agonist

Figure 10. Product Picture of Monoamine Oxidase Inhibitors

Figure 11. Product Picture of Acetylcholinesterase Inhibitors

Figure 12. Product Picture of Glutamate Inhibitors

Figure 13. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2021

Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Parkinson's Disease (PD) Drugs Consumed in Hospital

Figure 16. Global Parkinson's Disease (PD) Drugs Market: Hospital (2017-2022) & (K Pcs)

Figure 17. Parkinson's Disease (PD) Drugs Consumed in Family

Figure 18. Global Parkinson's Disease (PD) Drugs Market: Family (2017-2022) & (K Pcs)

Figure 19. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application in 2021

Figure 21. Parkinson's Disease (PD) Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Company in 2021

Figure 23. Global Parkinson's Disease (PD) Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Parkinson's Disease (PD) Drugs Sales 2017-2022 (K Pcs)

Figure 28. Americas Parkinson's Disease (PD) Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Parkinson's Disease (PD) Drugs Sales 2017-2022 (K Pcs)

Figure 30. APAC Parkinson's Disease (PD) Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Parkinson's Disease (PD) Drugs Sales 2017-2022 (K Pcs)

Figure 32. Europe Parkinson's Disease (PD) Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Parkinson's Disease (PD) Drugs Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2021

Figure 36. Americas Parkinson's Disease (PD) Drugs Revenue Market Share by Country in 2021

Figure 37. United States Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2021

Figure 42. APAC Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2021

Figure 43. China Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2021

Figure 50. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Parkinson's Disease (PD) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Parkinson's Disease (PD) Drugs in 2021

Figure 64. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs

Figure 65. Industry Chain Structure of Parkinson's Disease (PD) Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles